Holen Sie sich die Stockscreener-App
179.51
1.51%
2.68
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$176.83
Offen:
$176.78
24-Stunden-Volumen:
2.39M
Relative Volume:
0.42
Marktkapitalisierung:
$285.28B
Einnahmen:
$113.10B
Nettoeinkommen (Verlust:
$16.33B
KGV:
18.43
EPS:
9.7425
Netto-Cashflow:
$10.35B
1W Leistung:
+6.15%
1M Leistung:
+10.55%
6M Leistung:
+36.03%
1J Leistung:
+39.60%
1-Tages-Spanne:
$176.78
$180.65
1-Wochen-Bereich:
$168.10
$180.65
52-Wochen-Spanne:
$94.33
$180.65
Morgan Stanley Stock (MS) Company Profile
Firmenname
Morgan Stanley
Sektor
Branche
Telefon
212-761-4000
Adresse
1585 BROADWAY, NEW YORK, NY
Vergleichen Sie MS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
179.50 | 281.04B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
876.98 | 259.95B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
94.68 | 167.53B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
138.14 | 122.68B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
375.83 | 29.49B | 14.13B | 1.12B | 45.45M | 14.62 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-07-09 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-09-11 | Herabstufung | Goldman | Buy → Neutral |
| 2024-08-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-01-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-17 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-11-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-11-20 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | Herabstufung | Odeon | Buy → Hold |
| 2023-10-20 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-07 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-12 | Hochstufung | Odeon | Hold → Buy |
| 2023-01-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-10 | Hochstufung | Odeon | Sell → Hold |
| 2023-01-04 | Herabstufung | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | Herabstufung | Odeon | Hold → Sell |
| 2022-05-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-28 | Herabstufung | Odeon | Buy → Hold |
| 2021-12-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | Bestätigt | Jefferies | Buy |
| 2021-09-29 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-09-28 | Herabstufung | Berenberg | Buy → Hold |
| 2021-08-13 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2021-06-09 | Eingeleitet | Jefferies | Buy |
| 2021-04-21 | Hochstufung | Berenberg | Hold → Buy |
| 2021-03-02 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-11-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-10-13 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-06-24 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-06-23 | Bestätigt | UBS | Buy |
| 2020-05-21 | Hochstufung | Odeon | Hold → Buy |
| 2020-04-14 | Hochstufung | Societe Generale | Sell → Buy |
| 2020-03-13 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-21 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-01-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | Eingeleitet | DA Davidson | Buy |
| 2020-01-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-29 | Herabstufung | Odeon | Buy → Hold |
| 2019-10-10 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-18 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Morgan Stanley Aktie (MS) Neueste Nachrichten
DSGX: Morgan Stanley Raises Price Target to $110 | DSGX Stock Ne - GuruFocus
CRM Stock Update: Morgan Stanley Lowers Price Target | CRM Stock News - GuruFocus
Morgan Stanley Raises Price Target for PSKY Amidst Maintained Ra - GuruFocus
KYMR: Morgan Stanley Raises Price Target to $127, Maintains Over - GuruFocus
Antero Resources (AR) Target Price Raised by Morgan Stanley | AR Stock News - GuruFocus
Morgan Stanley Analyst Reduces Primerica, Inc. (PRI)’s Price Target In Response To Q3 Results - Yahoo Finance
Morgan Stanley B.V. announces partial cancellation of securities - Investing.com
Ferrari (BIT:RACE) Valuation Check After F1 Struggles and Morgan Stanley Downgrade Shift Market Sentiment - Yahoo Finance
Morgan Stanley (MS) Is Up 4.04% in One Week: What You Should Know - Nasdaq
REGEuronext DublinGEM-MSFPartial Retirement -09.12.2025 (MORGAN STANLEY FINANCE LLC) [85449] - TradingView
SLM Shares Fall After Downgrades From Morgan Stanley, Compass Point - marketscreener.com
Morgan Stanley tweaks Tesla stock price target with a twist - TheStreet
Morgan Stanley upgrades General Motors (GM) stock to overweight - MSN
Dyne Therapeutics' Recent DMD Study Data Further Validates Force Platform, Morgan Stanley Says - marketscreener.com
Morgan Stanley Maintains Bullish Stance on Apollo Global Management (APO) Stock - Insider Monkey
Form 424B2 MORGAN STANLEY - StreetInsider
What Morgan Stanley’s Downgrade Means for Tesla - Trefis
NewEdge taps ex-ICONIQ, Morgan Stanley executive as new CEO - InvestmentNews
Morgan Stanley Takes A Dimmer View Of HelloFresh - Finimize
Tesla Stock down 3.39% after Morgan Stanley Reevaluation - FXLeaders
Morgan Stanley Hands Tesla Stock New Rating And Sees Musk Hitting This Many Pay Deal Milestones - Investor's Business Daily
Tesla Stock Drops As New Morgan Stanley Analyst Downgrades Shares, Citing Valuation - The Wealth Advisor
Rivian (RIVN) Valuation Check After Morgan Stanley Downgrade and Rising ‘EV Winter’ Concerns - Yahoo Finance
Morgan Stanley Adjusts PT on Deere & Company to $560 From $500, Maintains Overweight Rating - marketscreener.com
Morgan Stanley's Mike Wilson: The Fed has more room to cut next year than people think - MSN
SLM Receives Downgrade from Morgan Stanley with Lower Price Targ - GuruFocus
Where Morgan Stanley thinks autonomous taxis will be in 2032 - Sherwood News
State Street Corp Sells 3,021,615 Shares of Morgan Stanley $MS - MarketBeat
Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO - GlobeNewswire Inc.
Morgan Stanley Downgrades SLM to Equalweight From Overweight, Adjusts PT to $31 From $36 - marketscreener.com
Antero Resources stock price target raised to $48 from $44 at Morgan Stanley - Investing.com
Morgan Stanley raises Paramount Skydance stock price target to $12 on new ownership strategy - Investing.com
Morgan Stanley sees more fuel for European defense stocks rally - TradingView
Morgan Stanley Raises Price Target on Mirum Pharmaceuticals to $95 From $81, Keeps Overweight Rating - marketscreener.com
Morgan Stanley Raises Price Target on Kymera Therapeutics to $127 From $73, Keeps Overweight Rating - marketscreener.com
Morgan Stanley PE Korea head Michael Hwey Hoon Chung steps down after 2 decades - KED Global
Morgan Stanley downgrades Tesla, warns stock reflects full AI and robotics valuation - CBT News
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley Raises Price Target on Dyne Therapeutics to $50 From $46, Keeps Overweight Rating - marketscreener.com
Europe’s Defense Rally Is Just Beginning, Says Morgan Stanley - Bloomberg.com
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley (NYSE:MS) Sets New 52-Week HighTime to Buy? - MarketBeat
Tesla stock slips 3.4% as Morgan Stanley cuts rating to Equal Weight - Traders Union
HelloFresh falls 5% after Morgan Stanley cuts rating on weak ready-to-eat data - Investing.com
Standard Chartered Joins JPMorgan and Morgan Stanley in Fed Rate Cut Call - InsuranceNewsNet
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Trucking Recovery Forecast for 2026: Supply-Side Catalyst Seen by Morgan Stanley - Global Trade Magazine
Morgan Stanley $MS Shares Purchased by Axa S.A. - MarketBeat
Morgan Stanley downgrades HelloFresh stock on ready-to-eat concerns - Investing.com
Finanzdaten der Morgan Stanley-Aktie (MS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):